US2007141033A1PendingUtilityA1
Purging of cells using viruses
Est. expiryJun 26, 2020(expired)· nominal 20-yr term from priority
Inventors:Harold AtkinsJohn BellConrad J. Heilman, Jr.Brian LichtyRobert M. LorenceMichael RobertsDavid F. Stojdl
A61P 35/00A61P 37/02A61P 37/06A61P 35/02A61K 35/14C12N 5/0093A61K 35/768A61K 35/765A61K 35/766A61P 29/00A61P 25/00C12N 2501/24A61K 35/28
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The subject invention relates to viruses that are able to purge (reduce or eliminate) undesirable cells in a mixture of cells. Undesirable cells can include neoplastic cells, cells mediating graft-versus host diseases, and autoimmune cells. The subject invention also relates to the purging of undesirable cells from bone marrow or peripheral blood cell harvests in the treatment of mammals including cancer patients, transplant recipients, and patients with autoimmune disease.
Claims
exact text as granted — not AI-modified1 . A method of reducing or eliminating neoplastic cells in an ex vivo mixture of normal, hematopoeitic cells and neoplastic cells, wherein the mixture is a suspension,
comprising incubating said mixture with an effective amount of a vesicular stomatitis virus, and administering an interferon to the mixture before, during or after incubating with said virus.
2 . A method as in claim 1 wherein said neoplastic cells are leukemia cells.
3 . A method as in claim 1 wherein said hematopoeitic cells are marrow cells.
4 . A method as in claim 1 wherein said hematopoeitic cells are peripheral blood cells.
5 . A method as in claim 1 wherein said virus is replication-competent.
6 . A method as in claim 1 wherein said neoplastic cells are lymphoma cells.
7 . A method as in claim 1 further comprising administering a chemotherapeutic agent to the mixture before, during or after incubating with said virus.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.